LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026)
LeonaBio (LONA) posted quarterly Change in Acquisitions & Divestments of $5.1 million for Q1 2026, up 78.07% year-over-year from $2.8 million in Q1 2025, and up 49.26% quarter-over-quarter from $3.4 million in Q4 2025.
LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 78.07% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $24.0 million (down 54.67% YoY), while the FY2025 annual figure was $21.7 million, down 68.48% from the prior year.
- Change in Acquisitions & Divestments rose to $5.1 million in Q1 2026 per LONA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $47.7 million in Q2 2023 and bottomed at $2.8 million in Q1 2025.
- Historically, Change in Acquisitions & Divestments has averaged $23.3 million across 5 years, with a median of $21.2 million in 2023.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments plunged 84.97% — and 2026, when it soared 78.07%.
- LeonaBio's Change in Acquisitions & Divestments stood at $34.8 million in 2022, then sank by 81.65% to $6.4 million in 2023, then surged by 182.26% to $18.0 million in 2024, then tumbled by 81.15% to $3.4 million in 2025, then jumped by 49.26% to $5.1 million in 2026.
- Business Quant data shows LONA's Change in Acquisitions & Divestments at $5.1 million in Q1 2026, $3.4 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Sep 30, 2023 | 23.50 Mn |